Skip to the page content
Your donations
Passes our checks

Human Cell Atlas Inc

EIN 85-0847756 · Cambridge, MA

Public records show a registered, tax-exempt organization in good standing.

LegitimacyPassesRegistration and standingFinancial healthFair60 out of 100GovernanceGood89 out of 100Impact evidenceDescribes programsHow well its results are evidenced

What it says it does

TO SUPPORT THE DEVELOPMENT OF A GLOBAL COLLABORATION AMONG RESEARCHERS TO DEVELOP A COMPREHENSIVE REFERENCE MAP OF ALL HUMAN CELLS AS A BASIS FOR UNDERSTANDING HUMAN HEALTH AND DIAGNOSING, MONITORING AND TREATING DISEASE; RECOMMEND BEST PRACTICES CONCERNING THE STORAGE, PROCESSING, AND ACCESS OF DATA COLLECTED THROUGH SUCH EFFORTS; AND ADVANCE THE PURSUIT OF RESEARCH AND EDUCATION IN SINGLE CELL AND SPATIAL GENOMICS AND RELATED SUBJECTS, INCLUDING PROTEOMICS AND OTHER "OMICS" FIELDS.

Income
$5.8 million
Spending
$5.5 million
Spent on programs
86%
Reserves
1.1 months of spending
Largest source of income
donations and private grants, 82%
Employees
0
Volunteers
8

Source: Form 990 for the year ending June 30, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Financial health

Fair: 60 out of 100. Higher than 29% of charities in its peer group (science, $1m to $10m).

  • Reserves

    10 of 35

    Spendable reserves would cover 1.1 months of spending.

  • Debt

    5 of 20

    It owes 72% of what it owns.

  • Living within its means

    15 of 15

    Income exceeded spending by 5% of income.

  • Income trend

    15 of 15

    Income rose 30% on the year before.

  • Spending floor

    15 of 15

    86% of spending went to programs and raising each dollar of donations cost 0 cents.

Source: Form 990 for the year ending June 30, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Governance

Good: 89 out of 100. Higher than 51% of charities in its peer group (science, $1m to $10m).

  • Independent board

    25 of 25

    8 of 8 voting board members are independent.

  • Conflict of interest policy

    15 of 15

    Has a written conflict of interest policy.

  • Whistleblower policy

    8 of 8

    Has a written whistleblower policy.

  • Record keeping policy

    7 of 7

    Has a written policy on keeping and destroying records.

  • Board minutes

    5 of 5

    Keeps minutes of board meetings.

  • Board sees the tax return

    0 of 10

    Did not give the board a copy of this return before filing it.

  • Independent check of accounts

    15 of 15

    Its accounts were audited by an independent accountant.

  • No reported misuse

    10 of 10

    Reports no diversion of assets, excess benefits or loans to insiders.

Source: Form 990 for the year ending June 30, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Impact evidence

Describes programs. Its tax return describes what it does but we have found no measurable results in it.

Programs described in its return (1)
  1. $4.8 million spent. SEE SCHEDULE OHUMAN CELL ATLAS, INC. OPERATES FOR EDUCATIONAL AND SCIENTIFIC PURPOSES TO SUPPORT THE DEVELOPMENT OF THE HUMAN CELL ATLAS - A COMPREHENSIVE REFERENCE MAP OF ALL HUMAN CELLS. THE HUMAN CELL ATLAS IS AN OPEN GLOBAL CONSORTIUM THAT CONSISTS OF OVER 3,900 MEMBERS FROM OVER 1,700 INSTITUTES AND 100 COUNTRIES. HUMAN CELL ATLAS, INC. PROVIDES SUSTAINABLE FINANCIAL MANAGEMENT FOR THE CENTRAL ACTIVITIES OF THIS CONSORTIUM AND ENSURES GLOBAL COMPLIANCE WITH REGIONAL AND NATIONAL DATA PROTECTION REGULATIONS. IN FISCAL YEAR 2025, HUMAN CELL ATLAS, INC. HELD VIRTUAL AND IN-PERSON MEETINGS, WORKSHOPS, AND SEMINARS, REACHING OVER 1,800 ATTENDEES IN OVER 55 COUNTRIES. OVER 450 SCIENTIFIC PUBLICATIONS TO DATE ARE PART OF THE HUMAN CELL ATLAS.THE ORGANIZATION IS COMMITTED TO CREATING AN OPEN, ETHICAL, EQUITABLE AND REPRESENTATIVE ATLAS FOR HUMANITY, WHICH WILL BENEFIT COMMUNITIES WORLDWIDE. HUMAN CELL ATLAS DATA IS BEING MADE AVAILABLE AT THE DATA COORDINATION PLATFORM FOR RESEARCHERS AROUND THE GLOBE. THROUGH FISCAL YEAR 2025, DATA SPANNING 530 PROJECTS, COMPRISING AN ESTIMATED 70.8 MILLION CELLS, HAS BEEN MADE AVAILABLE TO RESEARCHERS THROUGH THE PLATFORM.

Source: Form 990 for the year ending June 30, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Legitimacy checks

  1. Is it registered with the IRS? Passed.

    Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  2. Has the IRS revoked its tax-exempt status? Passed.

    Not on the IRS automatic revocation list.

    Source: Automatic revocation of exemption list, Internal Revenue Service, file dated November 6, 2026.

  3. Are donations tax-deductible? Passed.

    On the IRS list of organizations eligible to receive tax-deductible contributions.

    Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.

  4. Is it keeping up with its IRS filings? Passed.

    Most recent return on file covers the year ending June 2025.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  5. How long has it been tax-exempt? Passed.

    Recognized by the IRS since October 2021.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  6. Is it in good standing with state regulators? Passed.

    Not on California's list of charities barred from soliciting. Other states are not yet checked.

    Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated November 4, 2026.

Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.